Cryopreserved rat hepatocytes entrapped within an alginate matrix commercially available as Liverbeads™, were evaluated for their relevance as a screening tool for gene induction in vitro, using qRT-PCR. They were treated with the reference compounds betanaphthoflavone (BNF), phenobarbital (PB), pregnenolone 16α-carbonitrile (PCN) and clofibric acid (CLO) and analyzed for mRNA levels of Cyp1a1, Cyp2b1, Cyp3a1, Cyp4a1, Ugt1a6 and 
Introduction
Research and development of new chemicals is costly and time-consuming, which makes the identification of potential toxicity for new chemical entities critical during the early phase of their development. Hepatotoxicity is a very important cause of drug development arrest.
Chemical-induced changes in the level of expression of cytochrome P450 (P450) and other drug metabolizing genes can be indicators of liver tumor formation in rodents (Whysner et al., 1996) and are a key cause of drug-drug interactions. Hepatocyte-based screening in toxicology is largely used in order to reduce animal use and compounds development costs. Fresh and cryopreserved hepatocytes have long been considered as the most suitable in vitro model system for metabolism and toxicity studies. However, since rat primary hepatocyte monolayers exhibit a rapid decline in their P450 activities, various 2D (sandwich configuration for example) and 3D culture conditions have been proposed to improve both cell survival and metabolic competence (Guillouzo, 1998; Chia et al., 2000; Hewitt et al., 2007) . 3D models are receiving growing interest; among them gel entrapment offers the advantage of being highly protective during the freeze/thaw process (Guyomard et al., 1996; Rialland et al., 2000) . Indeed, after thawing hepatocyte viability is only slightly decreased and P450 activities remain expressed at levels comparable to those measured in primary hepatocyte monolayer cultures. Commercially available as Liverbeads™, alginate-entrapped hepatocytes from various species are a ready to use laboratory reagent, immediately available to laboratories without requiring any particular expertise in hepatocytes isolation.
Liverbeads™ have been used for interspecies xenobiotic metabolism investigations (identification of metabolite structures and analysis of metabolic clearance) (Guyomard et al., 1996) , determination of drug-metabolizing enzyme activities after xenobiotic exposure (Guyomard et al., 1996; Rialland et al., 2000) and evaluation of cytotoxic (Biagini et al., 2006) DMD #33753
Materials and Methods

Chemicals
Phenobarbital (PB), beta-naphthoflavone (BNF), clofibric acid (CLO), pregnenolone 16α-carbonitrile (PCN), phenytoin (PHE), clotrimazole (CTM) and dimethylsulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Quentin-Fallavier, France). Leibovitz-L15 (L15), HepatoZYME-SFM media and fetal calf serum (FCS) were supplied by Invitrogen (Cergy Pontoise, France). All chemicals used were of the highest quality available.
Cell culture and treatments
Cryopreserved male Wistar Rat Liverbeads™ were purchased from Biopredic International (Rennes, France) and cultured according to the manufacturer's instructions. Briefly, Liverbeads™ were rapidly thawed at 37°C and then put in L15 medium containing 0.6M glucose, 10mM Hepes, 100 IU/ml penicillin and 100µg/ml streptomycin and then distributed in 12-well plates (0.2 ml beads in 1 ml medium per well) for 3 hours in HepatoZYME-SFM medium containing 10% FCS, 4 µg/ml insulin, 2mM L-glutamine, 100 IU/ml penicillin and 100µg/ml streptomycin, at 37°C in 5% CO 2 /95% air. This medium was then replaced with the same medium supplemented or not with 1µM hydrocortisone hemisuccinate, deprived of FCS and containing the different test compounds or the vehicle. Liverbeads™ were thus exposed to 4 different concentrations of the test compounds PB (100, 300, 1000 and 3000 µM), BNF (1, 5, 10 and 20 µM), CLO (100, 200, 400 and 1000 µM) and PCN (1, 5, 10 and 30 µM) or to the vehicle control DMSO (0.2% final concentration) for 24, 48 or 72 h. Additional cultures were exposed to two concentrations of phenytoin (PHE) (10 and 200 µM) and clotrimazole (CTM) (2.5 and 10 µM) for 24 and 48 h. The test compound concentrations were selected from preliminary cytotoxicity experiments. This article has not been copyedited and formatted. The final version may differ from this version. 
In vivo dosing and experimental design
Male Wistar Rj:WI (IOPS HAN) rats, 6 week-old, were purchased from R. Janvier (Le Genest St Isle, France). Animal handling and experiments were performed in accordance with
The Guide for the Care and Use of Laboratory Animals (Council, 1996) . Each animal was individually housed in a stainless steel wire mesh cage under controlled environmental conditions and received drinking water and pelleted rodent diet (Scientific Animal Food and Engineering, Augy, France) ad libitum. After a 5 days acclimation and one day prior to treatment, each rat was assigned to a group by the stratified randomization method based upon the body weight. Animals (5 per group) were treated with a low (15 and 25 mg/kg/day) and a high (75 and 125 mg/kg/day) dose of PB and PCN respectively, by daily gavage for 7 days. Doses were chosen from literature (Guzelian et al., 2006; Nie et al., 2006; Slatter et al., 2006; Nioi et al., 2008) . Corn oil was used as a vehicle for all the compounds. Clinical observations were performed daily and body weights and physical examinations were recorded weekly. Twenty-four hours after the last dose, all animals were sacrificed by isoflurane (Baxter, Maurepas, France) inhalation followed by exsanguination under deep anesthesia. At necropsy, small pieces of the median and the left lobes of the liver of each animal were collected and flash-frozen in liquid nitrogen prior to storage at -80°C for the purpose of these investigations.
Total RNA isolation and quality control
Total RNA was isolated from individual control and treated liver samples or from Liverbeads™ cell lysates samples using RNeasy Mini kits (Qiagen, Valencia, CA) in accordance with manufacturer's instructions. Resulting total RNA was quantified using a NanoDrop ND-1000 (NanoDrop Technologies, Inc., Montchanin, DE). RNA integrity (28S/18S ratio) and purity were assessed using RNA 6000 nano assay LabChips ® (Agilent Technologies, Santa Clara, CA) and analyzed on a 2100 Bioanalyzer (Agilent Technologies). 
, where Δ C t values of the sample and calibrator were determined by subtracting the average C t value of the transcripts from the average C t value of B2m mRNAs for each sample. RQ of the control sample was always equal to one. A change was considered as significant when RQ was above 1.5 or below 0.5.
Statistical analysis
Statistical analysis was performed using a two-way ANOVA test with a Bonferroni posthoc test. The values were expressed as mean ± SD and a p-value ≤ 0.05 was considered as statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Steady-state RNA levels in Liverbeads during culture
mRNA levels of Cyp1a1, Cyp2b1, Cyp3a1, Cyp4a1, Ugt1a6 and Ugt2b1 were measured in rat Liverbeads™ after 0, 24, 48 and 72 h of culture in a medium containing 0.2% DMSO and 1µM hydrocortisone hemisuccinate (Fig. 1 ). Compared to values found just after thawing (0 h), those measured in 24 h cultures were either unchanged (Cyp3a1), significantly increased (Cyp1a1, Ugt1a6) or decreased (Cyp2b1, Cyp4a1, Ugt2b1). At 48 h, with the exception of Cyp4a1 mRNA which was slightly more decreased, transcript levels of all other genes were enhanced (Cyp2b1: 10 to 20-fold and Ugt2b1: 15 to 30-fold) and Cyp3a1 transcript levels were around 6-fold increased, compared to 24 h. At 72 h, for all the genes tested, the transcript levels were relatively unchanged (Cyp4a1) or still higher (all other genes) compared to the 48 h time point. Either 1µM hydrocortisone (data not shown) or 0.2% DMSO (supplemental Table 1S ) had no influence on the levels of the transcripts whatever the gene tested and the time of culture
Time-and concentration-dependent responsiveness of Liverbeads™ following exposure to reference compounds
The effects of BNF, PB, CLO and PCN on the 6 drug metabolizing genes of interest were studied in Liverbeads™ after 24, 48 and 72h of exposure. Several concentrations of each compound were selected from preliminary experiments. The highest concentration used was based on either the maximum non-toxic concentration after 24 and 72 h treatment using the Table 1A and Table 1B , respectively. All corresponding data with means and SDs are displayed in the supplemental Table 2S .
BNF strongly induced Cyp1a1 mRNA levels (Table 1A and 1B) in a concentrationdependent manner and maximum induction was observed after a 24h exposure with 10µM. In addition Ugt1a6 and Cyp2b1 transcripts were also moderately increased, not exceeding 3-fold, with the exception of Cyp2b1 which was increased 7-fold after 72h with the highest BNF concentration (20µM). No noticeable changes were observed for the three other genes.
PB induced a strong increase in Cyp2b1 mRNA levels (Table 1A and 1B). This increase was already high after a 24h treatment with the lowest concentration (100 µM) and the highest fold-change reached 200 at 48 hr with 3000µM. PB also induced, but to a lower extent, Ugt2b1, Cyp1a1 and Cyp3a1 mRNA levels, mainly after 48 and 72h. Other genes were either unchanged (Ugt1a6) or even decreased (Cyp4a1 at 72 h).
CLO mainly induced Cyp4a1 gene (Table 1A and The reproducibility of the responsiveness of Liverbeads™ batches to reference inducers was confirmed by treating 3 other different Liverbeads™ batches with two concentrations of PB (100 and 1000 µM) and PCN (2 and 10 µM) for 24, 48 and 72h. The data displayed in Figure 2 mostly confirmed those obtained with the original batch (Table 1A and 1B) . Indeed, Cyp2b1 transcripts were strongly induced by PB in a time-dependent manner with the levels being slightly higher with 1000µM versus 100µM. Cyp1a1, Cyp3a1 and Ugt2b1 were also induced but to a much lower extent than Cyp2b1 and usually only after 48 and 72h of treatment with the 1000µM PB concentration. The initial results obtained with PCN (Table 1) were confirmed ( Fig   2B) . A limited but significant increase in Cyp3a1 and Ugt2b1 was observed as early as 24 h after exposure to 2 and 10µM PCN. In addition, Cyp2b1 was also increased but only after 24 h treatment. Ugt1a6 remained unchanged and Cyp4a1 expression was decreased after exposure to 10µM PCN for 48 and 72h. No change in the fold-inductions was observed in Liverbeads™ cultured in hydrocortisone-free medium compared to in the presence of hydrocortisone with the exception of Cyp3a1 which was slightly more increased (2-versus 1.5-fold) in the presence of hormone (data not shown).
The responsiveness of Liverbeads™ to known inducers which are modulators of CAR and PXR was confirmed by treatment with PHE and CTM for 24 and 48 h. PHE was used at 10 and 200µM and CTM at 2.5 and 10µM. The data, displayed in Table 2 , showed that the effects of these two inducers were very close to those obtained with their corresponding CAR and PXR ligands, PB and PCN, respectively. They induced the same P450s and UGT to a similar extent in a dose-dependent manner.
This article has not been copyedited and formatted. The final version may differ from this version. Finally, to determine whether Liverbeads™ are representative of the in vivo liver for xenobiotic gene induction screening, rats were also treated with two doses of PB and PCN by daily gavage for 7 days (Fig. 3) . As shown in Figure 3A , at the low dose of 15mg/kg, PB significantly induced only the two most sensitive genes, Cyp2b1 and Ugt2b1, while at 75mg/kg the expression of three additional genes, Cyp1a1, Cyp3a1 and Ugt1a6, was increased. These in vivo results correlated well with the in vitro findings (Table 1A and 1B and Fig. 2A) 
Discussion
It is well established that P450 expression and activity rapidly decline in conventional hepatocyte monolayers, resulting in a low biotransformation of xenobiotics and in the loss of responsiveness to some metabolic enzyme inducers, especially PB (Su and Waxman, 2004; Nishimura et al., 2007) . The loss of P450 expression and activity does not affect all P450s in the same way and even a transient increase of Cyp1a1 has been observed (Wortelboer et al., 1990) .
Phase 2 enzymes undergo a similar loss (Kern et al., 1997) . Although a less rapid decline in P450 performance is observed in rat hepatocytes maintained in the 2D sandwich configuration (Schuetz et al., 1988; De Smet et al., 2001; Sidhu et al., 2004) , there are limitations to such extracellular matrix-based sandwich cultures. These limitations are due to mass transfer barriers and the fact that protocols for RNA and protein extraction from such cultures are either timeconsuming or contain steps that may skew the results. We show here that, contrary to rat hepatocytes in monolayers or in a sandwich configuration, alginate-entrapped rat hepatocytes exhibited a slight or marked increase in transcript levels for most CYP (with the exception of Cyp4a1 which showed a decrease then stabilized) and UGT genes tested between 24 and 72 h in control culture conditions, indicating that in this configuration cryopreserved rat hepatocytes maintained a good expression of genes involved in xenobiotic metabolism.
Several studies have shown that cryopreservation does not alter levels of total cytochrome P450 and phase 1 enzyme activities when measured shortly after thawing in hepatocytes plated in conventional monolayer or in a sandwich configuration (Chesne et al., 1993; Madan et al., 1999) or immobilized in alginate gels (Rialland et al., 2000) . However changes in the levels of corresponding mRNAs usually occur early and are much more drastic in conventional monolayer compared to Liverbeads™. Therefore the fact that cryopreserved alginate-entrapped hepatocytes showed increased mRNA levels between 24 and 72 h of culture and were strongly responsive to This article has not been copyedited and formatted. The final version may differ from this version. most of the reference inducers tested is of major importance for metabolism gene induction investigations.
Indeed, consistent with previous studies in vivo (Heuman et al., 1982; Wrighton et al., 1985; Baldwin et al., 2006) and in vitro (Kocarek et al., 1995; Meredith et al., 2003) , a marked increase was observed in mRNA levels of induced P450s after treatment with corresponding reference inducers. BNF was an effective inducer of Cyp1a1 and Ugt1a6; PB of Cyp2b1, Ugt2b1 and Cyp3a1; PCN of Cyp3a1 and Ugt2b1 and CLO of Cyp4a1. Induction of Cyp3a1 by PB and Cyp2b1 by PCN can be explained by the crosstalk between the nuclear receptors CAR and PXR (Moore et al., 2000; Pascussi et al., 2008) . In addition, in agreement with other reports, transcripts of additional CYPs were found to be increased in Liverbeads™ but usually only after prolonged treatment and at a lower extent compared to the major P450s. For example, we observed an increase in mRNA levels of Cyp2b1 with BNF and CLO which was coherent with previously published data (Richert et al., 2003; Richert et al., 2009 ). The slight increase of Cyp1a1 by PHE could be related to its PB-like properties. Some discrepancies were also noticed.
Thus, Cyp1a1 was induced by PCN in rat liver but the fold induction was low and observed after 7 days of treatment with the highest dose (125mg/kg). Likely, small fold-inductions of drug metabolizing enzymes, occurring in vitro or in vivo after several days of exposure and usually with high chemical doses, involved different mechanisms than those implicated in the induction of early responsive genes.
The maximum fold induction of individual P450 genes varied greatly reaching for example 200-fold for Cyp2b1 with PB, 65-fold for Cyp4a1 with CLO, 14-fold for Cyp1a1 with BNF and 2-fold for Cyp3a1 with PCN. However it must be borne in mind that Cyp1a1, for example, is constitutively expressed at extremely low levels in the rat liver and that among the various parameters that can modulate the responsiveness of P450s (Burczynski et al., 2001) , their (Guillouzo and Guguen-Guillouzo, 2008) . Only Cyp3a1 exhibited a limited fold induction level, not exceeding 2-fold and lower than the values found in other hepatocyte culture models (Kocarek et al., 1995; Meredith et al., 2003) . However the increase was statistically significant after treatment with both PCN and CTM. It is interesting to note that this P450 was the most stable during the first 24h. The slightly higher fold-induction of Cyp3a1 in hydrocortisone-free medium could reflect a slight induction effect of this hormone on this P450
without any chemical treatment. An important finding was the very good reproducibility of the data between the different batches of Liverbeads making this model an appropriate in vitro model for xenobiotic gene induction studies.
Several studies have reported induction by DMSO of several P450s, especially the CYP3A subfamily, in both primary hepatocytes (LeCluyse et al., 2000; Su and Waxman, 2004; Lin, 2006) and hepatoma cell lines (Aninat et al., 2006) . Although most effects were obtained with a 2% DMSO concentration, some increase was also evidenced with concentrations as low as 0.1% in primary human hepatocytes (LeCluyse et al., 2000) . In the present study we did not observe any significant effect of DMSO in the transcript levels of all P450s tested in the presence of 0.2% DMSO. A likely explanation is that we used rat hepatocytes and that the basal P450 levels are better preserved in Liverbeads™ than in primary hepatocyte cultures.
Our in vitro results with the Liverbeads™ model were in line with our in vivo studies with PB and PCN which are in agreement with previous in vivo studies in which similar dose levels were used and similar P450 induction profiles obtained (Wyde et al., 2003; Guzelian et al., 2006; Slatter et al., 2006 Tables   Table 1A: 
